Advertisement
Screener

GAIN THERAPEUTICS, INC (GANX) ROI

GAIN THERAPEUTICS, INC (GANX) ROI

  • 2026-06-30: ROI -172.80%.
  • 2026-03-31: ROI -147.70%.
  • 2025-12-31: ROI -106.30%.
  • 2025-09-30: ROI -306.16%.

Complete source-backed roi history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-30-172.80%
2026-03-31-147.70%
2025-12-31-106.30%
2025-09-30-306.16%
2025-06-30-448.29%
2025-03-31-337.14%
2024-12-31-262.42%
2024-09-30-227.22%
2024-06-30-176.02%
2024-03-31-231.09%
2023-12-31-169.39%
2023-09-30-282.13%
2023-06-30-189.00%
2023-03-31-123.71%
2022-12-31-90.29%
2022-09-30-69.41%
2022-06-30-58.76%
2022-03-31-45.30%
2021-12-31-39.12%
2021-09-30-32.22%
2021-06-30-20.09%
2021-03-31-12.05%
2020-12-31-51.55%

Annual ROI

DateROI
2025-12-31-106.30%
2024-12-31-262.42%
2023-12-31-169.39%
2022-12-31-90.29%
2021-12-31-39.12%
2020-12-31-51.55%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lifevantage Corp (LFVN)United States$0.078B15.40
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Valion Bio, Inc. (VBIO)United States$0.077B
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
iBio, Inc. (IBIO)United States$0.077B-2.94
Telomir Pharmaceuticals, Inc. (TELO)United States$0.084B
Lexaria Bioscience Corp. (LEXX)$0.084B-1.92
Verrica Pharmaceuticals Inc. (VRCA)United States$0.076B-3.39
OS Therapies Inc (OSTX)United States$0.076B-2.17
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)United States$0.086B